聖農發展(002299.SZ):聖澤901白羽肉雞取得畜禽新品種(配套系)證書
格隆匯12月6日丨聖農發展(002299.SZ)公佈,公司及全資子公司福建聖澤生物科技發展有限公司自主研發的白羽肉雞配套系“聖澤901”,於近日經國家畜禽遺傳資源委員會審定、鑑定通過,並正式取得國家畜禽遺傳資源委員會頒發的《畜禽新品種(配套系)證書》。
公司潛心十餘年白羽肉雞育種工作,成功鍛造出“聖澤901”白羽肉雞配套系並取得官方認可,有利保障了公司“十四五”規劃的實施,為解決中國白羽肉雞種源“卡脖子”問題貢獻了一份力,加快了中國白羽肉雞國產化的實現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.